Active ingredientNelfinavirCat. No. P-N030-001CAS 159989-64-7Family · Pharmaceutical analytical standards
Nelfinavir
A first-generation HIV protease inhibitor, approved in the United States in March 1997 for the treatment of HIV infection, in combination with other antiretrovirals. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It has also been studied as a possible anticancer drug: in 2007 it was shown to slow the growth of many tumour cell lines in the NCI60 panel used by the US National Cancer Institute.
Go to the active ingredient →Active ingredientNelfinavirCat. No. P-N030-001CAS 159989-64-7
Active ingredientNelfinavir MesylateCat. No. P-N030-002CAS 159989-65-8
Isotopically labelledNelfinavir-d3Cat. No. P-N030-003CAS 1217629-70-3
ImpurityDiphenyl disulfideCat. No. P-N030-005CAS 882-33-7
ImpurityNelfinavir Hydroxy-tert-butylamideCat. No. P-N030-006CAS 213135-56-9
ImpurityNelfinavir Oxazole ImpurityCat. No. P-N030-007CAS 188936-07-4
ImpurityNelfinavir RegeoisomerCat. No. P-N030-008
ImpurityNelfinavir SulfoneCat. No. P-N030-009CAS 1041389-29-0
ImpurityNelfinavir SulfoxideCat. No. P-N030-010CAS 1041389-28-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.